Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis

Background/Aims There is little evidence to guide the management of antiplatelets/anticoagulants (AP/AC) during endoscopic variceal band ligation (EVBL). This study aims to assess bleeding complications following EVBL performed with AP/AC. Methods We retrospectively assessed all EVBL cases performed at our centre over a 10-year period (January 2010 to August 2020), comparing outcomes of those on AP/AC during EVBL versus those not on AP/AC. Secondary analysis was of patients continuing AP/AC versus those who withheld usual AP/AC. Results A total of 1,570 episodes of EVBL were analysed (116 AP/AC, 1,454 off AP/AC). Mean age was 56.2 years, 75.6% were male, and mean model for end stage liver disease score was 14. No difference was found between groups for 30-day bleeding rates (3/116 cases [2.6%] on AP/AC, 52/1,454 cases [3.6%] off AP/AC, p =0.58), or overall 30-day mortality (3/116 cases [2.6%] on AP/AC, 18/1,454 cases [1.2%] off AP/AC, p =0.22). Similarly, 30-day bleeding rates did not differ between AP/AC patients continuing (3/110 cases [2.7%]) versus those withholding therapy (6/123 cases [4.9%], p =0.40). Conclusions In a large cohort of patients undergoing EVBL, continuation of AP/AC therapy was not associated with an elevated risk of rebleeding. This adds further evidence to support current recommendations to continue such therapy for patients undergoing endoscopy for varices.

Authors

Institutions

Publication Details

Journal
Clinical Endoscopy
Published
2026-11-17
DOI
https://doi.org/10.5946/ce.2025.442
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis

Monique Fernandez, Thomas Worland, Roseanne Kimberley Chan, Jack Whitelaw et al.
1 links
Clinical Endoscopy
Liver Disease and Transplantation
article

Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis

Monique Fernandez, Thomas Worland, Roseanne Kimberley Chan, Jack Whitelaw, Nicola Tomkins, Gordon Chen, Marie J. Sinclair, Karla Cameron, Jonathan Ng, Gabrielle Hoskin, Catherine Yu, Samuel Hui
article en

Abstract

Background/Aims There is little evidence to guide the management of antiplatelets/anticoagulants (AP/AC) during endoscopic variceal band ligation (EVBL). This study aims to assess bleeding complications following EVBL performed with AP/AC. Methods We retrospectively assessed all EVBL cases performed at our centre over a 10-year period (January 2010 to August 2020), comparing outcomes of those on AP/AC during EVBL versus those not on AP/AC. Secondary analysis was of patients continuing AP/AC versus those who withheld usual AP/AC. Results A total of 1,570 episodes of EVBL were analysed (116 AP/AC, 1,454 off AP/AC). Mean age was 56.2 years, 75.6% were male, and mean model for end stage liver disease score was 14. No difference was found between groups for 30-day bleeding rates (3/116 cases [2.6%] on AP/AC, 52/1,454 cases [3.6%] off AP/AC, p =0.58), or overall 30-day mortality (3/116 cases [2.6%] on AP/AC, 18/1,454 cases [1.2%] off AP/AC, p =0.22). Similarly, 30-day bleeding rates did not differ between AP/AC patients continuing (3/110 cases [2.7%]) versus those withholding therapy (6/123 cases [4.9%], p =0.40). Conclusions In a large cohort of patients undergoing EVBL, continuation of AP/AC therapy was not associated with an elevated risk of rebleeding. This adds further evidence to support current recommendations to continue such therapy for patients undergoing endoscopy for varices.

Clinical Endoscopy
The University of Melbourne (AU), Austin Hospital (AU), Melbourne Bioinformatics (AU), Austin Health (AU)
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon